The U.S. Food and Drug Administration (FDA) released the following two draft guidance documents: Coronary, Peripheral, and Neurovascular Guidewires - Performance Tests and Recommended Labeling; and Intravascular Catheters, Wires, and Delivery Systems with Lubricious Coatings - Labeling Considerations.

Henry Ford Hospital is one of 17 U.S. trial sites using a catheter-based procedure approved in Europe to repair a leaky mitral heart valve.

The thought of losing up to $14 a week along with personalized goal setting may have motivated ischemic heart disease patients to increase their exercise, according to a new clinical trial published in Journal of the American Heart Association, the Open Access Journal of the American Heart Association/American Stroke Association.

Volta Medical, out of Marseille, France, has developed the first artificial intelligence (AI) software to guide cardiologists during heart surgeries to treat atrial fibrillation (AF) or any open-heart surgery.

NewYork-Presbyterian, in collaboration with Weill Cornell Medicine, Columbia University Irving Medical Center and the Fire Department of New York (FDNY), is expanding its fleet of Mobile Stroke Treatment Units (MSTU) to Queens and Brooklyn. Thanks to a generous donation by the W.P. Carey Foundation, this makes NewYork-Presbyterian the first health system in the country to operate three of these advanced units.

A new report from the U.S. Food and Drug Administration (FDA) discusses the continued quality, safety and effectiveness of servicing of medical devices by original equipment manufacturers (OEMs) and third-party entities.

June 7, 2018 — The first clinical cases have been completed where the Emboliner Embolic Protection Catheter was used ...

June 6, 2018 — Maquet Datascope Corp. said it is recalling the CardioSave Hybrid Intra-aortic Balloon Pump (IABP) due to ...